Does delay to the time of lumpectomy impact your decision to omit radiation?

There seem to be two issues to consider in this situation. One is whether patients undergoing neoadjuvant endocrine therapy, then lumpectomy without RT, have an acceptable local recurrence rate. The only study I know of directly addressing this issue was presented at a poster session of the 2017 San...

I would follow the same principle as I would use for low-risk ER-positive disease in those 65 and above.

Omission or APBI